Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs

被引:29
作者
Gedge, Lukyn M. [1 ]
Bettis, Alison A. [2 ,3 ]
Bradley, Mark H. [4 ]
Hollingsworth, T. Deirdre [5 ,6 ,7 ]
Turner, Hugo C. [8 ,9 ]
机构
[1] Imperial Coll London, Fac Med, Sch Publ Hlth, St Marys Campus,Norfolk Pl, London W2 1PG, England
[2] London Ctr Neglected Trop Dis Res, London, England
[3] Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England
[4] GlaxoSmithKline, Global Hlth Programs, Brentford, England
[5] Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England
[6] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England
[7] Univ Oxford, Big Data Inst, Oxford OX3 7LF, England
[8] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam
[9] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England
基金
英国惠康基金;
关键词
Lymphatic filariasis; Cost-benefit; Cost-effectiveness; Economic evaluations; Economic impact; GPELF; Programme evaluation; NEGLECTED TROPICAL DISEASES; COST-EFFECTIVENESS THRESHOLDS; MIDDLE-INCOME COUNTRIES; RURAL COMMUNITIES; IVERMECTIN TREATMENT; VECTOR CONTROL; WORK TIME; ONCHOCERCIASIS; DIETHYLCARBAMAZINE; BURDEN;
D O I
10.1186/s13071-018-2616-z
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
In 2000, the World Health Organization established the Global Programme to Eliminate Lymphatic Filariasis (GPELF), with the goal of eliminating the disease as a public health problem by 2020. Since the start of the programme, a cumulative total of 6.2 billion treatments have been delivered to affected populations with more than 556 million people treated in 2015 alone. In this paper, we perform a rigorous systematic review of the economic evaluations of lymphatic filariasis interventions have been conducted. We demonstrate that the standard interventions to control lymphatic filariasis are consistently found to be highly cost-effective. This finding has important implications for advocacy groups and potential funders. However, there are several important inconsistencies and research gaps that need to be addressed as we move forward towards the 2020 elimination goals. One of the most important identified research gaps was a lack of evaluation of new interventions specifically targeting areas co-endemic with onchocerciasis and Loa loa - which could become a major barrier to achieving elimination.
引用
收藏
页数:18
相关论文
共 105 条
[1]  
Addiss David G, 2007, Filaria J, V6, P2, DOI 10.1186/1475-2883-6-2
[2]   Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis [J].
Aljayyoussi, Ghaith ;
Tyrer, Hayley E. ;
Ford, Louise ;
Sjoberg, Hanna ;
Pionnier, Nicolas ;
Waterhouse, David ;
Davies, Jill ;
Gamble, Joanne ;
Metugene, Haelly ;
Cook, Darren A. N. ;
Steven, Andrew ;
Sharma, Raman ;
Guimaraes, Ana F. ;
Clare, Rachel H. ;
Cassidy, Andrew ;
Johnston, Kelly L. ;
Myhill, Laura ;
Hayward, Laura ;
Wanji, Samuel ;
Turner, Joseph D. ;
Taylor, Mark J. ;
Ward, Stephen A. .
SCIENTIFIC REPORTS, 2017, 7
[3]  
[Anonymous], 2017, Wkly Epidemiol Rec, V92, P594
[4]  
[Anonymous], 2016, Wkly Epidemiol Rec, V91, P441
[5]  
[Anonymous], 2012, Wkly Epidemiol Rec, V87, P1
[6]  
[Anonymous], CPI INFL CALC
[7]  
[Anonymous], CONTR PHARM CO CONTR
[8]  
[Anonymous], 1993, WORLD DEV REPORT 199
[9]   Treatment costs and work time loss due to episodic adenolymphangitis in lymphatic filariasis patients in rural communities of Orissa, India [J].
Babu, BV ;
Nayak, AN .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2003, 8 (12) :1102-1109
[10]   The economic loss due to treatment costs and work loss to individuals with chronic lymphatic filariasis in rural communities of Orissa, India [J].
Babu, BV ;
Nayak, AN ;
Dhal, K ;
Acharya, AS ;
Jangid, PK ;
Mallick, G .
ACTA TROPICA, 2002, 82 (01) :31-38